Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/ABCL
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

AbCellera Biologics Inc (ABCL) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

AbCellera Biologics (ABCL) trades at $11.44, up 0.09% with strong institutional interest following positive Phase 2 results for its menopause treatment ABCL635. The stock has surged over 250% year-to-date, supported by a $200 million oversubscribed public offering. Despite negative profit margins, revenue growth from $29M to $75M (2024-2025) and analyst consensus of $15.50 price target reflect optimism. Technical indicators show bullish momentum with RSI at neutral levels and key support at $11.
Outlook remains positive driven by clinical progress and biotech sector tailwinds, but risks include persistent cash burn (-$131M operating cash flow) and high valuation multiples (P/S 52.14). The company's path to profitability hinges on successful drug commercialization, with current investor sentiment buoyed by institutional backing and recent trial successes.
Read full analysis

Key Stats

  • Market Cap
    $3.71B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $12.50
  • 52W Low
    $2.78
  • Typical Hold Time
    -
  • Enterprise Value
    $3.30B
  • Div Yield
    -
  • Trading Activity
    -
$11.12
52W Low: $2.78
05 Feb 2026
52W High: $12.5
25 Aug 2026

Track AbCellera Biologics Inc (ABCL) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, AbCellera Biologics Inc has traded between a low of $2.78 and a high of $12.5, highlighting its annual price range. Buy and sell AbCellera Biologics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Most Recent News

Content is generated by Aura AI

Barrick Mining keeps 'Outperform' rating as gold production rises 11% in Q2, trading at a 15% valuation discount.

Barrick Mining maintains an 'Outperform' rating from Bernstein despite a lowered price target of $56.50, down from $61.00. The company reported an 11% increase in gold production in Q2 to 796,000 ounces, with further growth expected in the coming qua...

Analyst Insights
2 hours ago
Alex Lavoie
Bullish
news icon
Barrick Mining keeps 'Outperform' rating as gold production rises 11% in Q2, trading at a 15% valuation discount.

UnitedHealth stock falls 3% as TPG invests in Florida WellMed clinics before guidance update

UnitedHealth's stock dropped 3% after Bloomberg reported the company sold a stake in its Florida WellMed primary-care clinics to TPG. This move comes just hours before UnitedHealth is set to reaffirm its full-year 2026 financial guidance, which could...

Market News
4 hours ago
24/7 Wall Street
Bearish
news icon
UnitedHealth stock falls 3% as TPG invests in Florida WellMed clinics before guidance update

GameChange Energy sues Nextpower for patent infringement over solar tracker technology

GameChange Energy's subsidiary, GameChange Solar Corp., has filed a patent infringement lawsuit against Nextpower in Delaware, accusing them of violating a patent on its high-tilt stow technology used in solar trackers. The technology is designed to ...

Market News
4 hours ago
PRNewsWire
Bearish
news icon
GameChange Energy sues Nextpower for patent infringement over solar tracker technology
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $3.71B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $12.50
  • 52W Low
    $2.78
  • Typical Hold Time
    -
  • Enterprise Value
    $3.30B
  • Div Yield
    -
  • Trading Activity
    -
$11.12
52W Low: $2.78
05 Feb 2026
52W High: $12.5
25 Aug 2026

Track AbCellera Biologics Inc (ABCL) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, AbCellera Biologics Inc has traded between a low of $2.78 and a high of $12.5, highlighting its annual price range. Buy and sell AbCellera Biologics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!